EUVIMEDEUVIMED entdecken
Crossref

Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors

Taylor E Escher, Simseok A Yuk, Yuan Qian, Wenan Qiang, Sultan Almunif, Swagat Sharma, Evan A Scott iD, Karla J F Satchell iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c00179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Taylor E Escher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, RNA, Messenger, Biocompatible Materials, ras Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Cancer Institute, Chicago Biomedical Consortium, Office of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsRNA, MessengerBiocompatible Materialsras ProteinsNanoparticlesGene Transfer TechniquesHumansCell ProliferationAnimalsCell Line, TumorPolyethylene GlycolsMiceMaterials TestingParticle Size

Stichwörter der Autor:innen

RASRRSPdegradermRNAnanoparticleproteasesynthetic nanocarrier

Substanzen

RNA, MessengerBiocompatible Materialsras ProteinsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
  • Department of Biomedical Engineering, Northwestern University, Evanston, Illinois 60208, United States.
  • Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
  • Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208, United States.
  • Robert H. Lurie Comprehensive Cancer Research Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
  • Bioengineering Institute, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.

ORCID-Profile: Evan A Scott, Karla J F Satchell

Förderung

  • National Cancer Institute
  • Chicago Biomedical Consortium
  • Office of Science
  • Horizon 2020 Framework Programme
  • National Science Foundation
  • SQI Synthesizer Grant Program

Zitieren

APA

Escher, T. E., Yuk, S. A., Qian, Y., Qiang, W., Almunif, S., Sharma, S., Scott, E. A., & Satchell, K. J. F. (2025). Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00179

Vancouver

Escher TE, Yuk SA, Qian Y, Qiang W, Almunif S, Sharma S, et al. Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00179

BibTeX
@article{Escher2025,
  author = {Escher, Taylor E and Yuk, Simseok A and Qian, Yuan and Qiang, Wenan and Almunif, Sultan and Sharma, Swagat and Scott, Evan A and Satchell, Karla J F},
  title = {Expression of a RAS Degrader via Synthetic Nanocarrier-Mediated mRNA Delivery Reduces Pancreatic Tumors},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c00179}
}
Kostenlos starten →